Baduanjin Sequential Therapy and Cardiac Function of AMI With Reduced EF After PCI — BST-AMI  

AMI Clinical Trial

Official title: Effect of Baduanjin Sequential Therapy on the Cardiac Function and Exercise Endurance in Patients With AMI and Reduced Ejection Fraction After Primary PCI

Status Recruiting

Clinical Trial Summary

Acute myocardial infarction (AMI) is one of the leading causes of death around the world, with the potential for substantial morbidity and mortality. The increasing evidence indicates that exercise training has beneficial effects on LV remodelling in post-MI patients with greater benefits occurring when training earlier following MI, among which the earliest time for rehabilitation is one week after myocardial infarction. However, the effect of Baduanjin sequential therapy for patients after one week of AMI has yet to be assessed. Therefore, the aim of this study is to assess the impact of Baduanjin sequential therapy on cardiac and physical function in patients with AMI and reduced ejection fraction after primary PCI.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• AMI

• NCT number: NCT05201274
• Study type: Interventional
• Source: Shenyang Northern Hospital
• Contact: Meili Liu, MD
• Phone: 86-18940193302
• Email: liumeili1983bl@163.com
• Status: Recruiting
• Phase: N/A
• Start date: November 11, 2021
• Completion date: February 11, 2023